AVRNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Anteris Technologies Global Corp.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$6.18+0.13 (+2.15%)
Close on Oct 19, 2026
- Market cap
- $601.56M
- P/E (TTM)
- –
- Dividend yield
- –
Anteris Technologies Global Corp. revenue by segment
By business segment
By product or service
By region
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|
| United States | $2.20M | $1.82M | $1.61M | $1.53M | $1.56M | $1.45M | $1.78M | 98.2% | +41.5% |
| Australia | $41.00K | $35.00K | $33.00K | $33.00K | $30.00K | $26.00K | $21.00K | 1.8% | +36.7% |
| Germany | $0 | $0 | $272.00K | $575.00K | $894.00K | $1.02M | $900.00K | 0.0% | -100.0% |
From the segment and revenue-disaggregation notes of Anteris Technologies Global's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.